November 13, 2006 May 15, 2020 Subjects : Clarification of Operating Performance for the Q1/2020 Attention : The Director and Manager of the Stock Exchange of Thailand The Consolidated net profit of
No. Lor Gor. 009/2020 June 12, 2020 President The Stock Exchange of Thailand Re : Investment in debentures from connected party Dear Sir, Thai Wacoal Public Company Limited wishes to hereby report to
Page 1 Date 11 November 2020 Re: Management Discussion & Analysis for the 9-months period Ended 30 September 2020 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN PUBLIC
No. MVP067/2020 November 16, 2020 Subject: Management Discussion and Analysis for the three – month and nine – month periods ended September 30, 2020 To: President and Manager The Stock Exchange of
the 3rd quarter ended 30 September 2019 Attn: Director and Manager, The Stock Exchange of Thailand With respect to the financial information for the 3rd quarter ended 30 September 2019, as submitted by
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
Page 1 No. CMC Sor Lor.013/2019 Date 12 November 2019 Re: Management Discussion & Analysis for the Period Ended 30 September 2019 To The President of the Stock Exchange of Thailand (SET
No. ADD-IR2021/001 19 May 2021 Subject: Management discussion and analysis for the performance for the three-month period ended 31 March 2021 To: President The Stock Exchange of Thailand AddTech Hub
Ref. APURE 024/2023 August 15, 2023 Subject : Financial Position and Operating Performance of year 2022 (Revise) Attention : The Director and President of the Stock Exchange of Thailand Financial
supporting the protection of investor personal data, to ease the burden of cost of the investors to repeatedly provide such data when switching their services.Mr. Boonsun Prasitsumrit, Chief Executive